الفهرس 
Uterine Cavity AbnormalitiesOnly 14 pages are availabe for public view
 |  | from | 158 |  |  |
| | | from | 158 | | |
Abstract
It is a prospective randomized controlled study that was done during the period from January 2016 to January 2019, in gynecology & obstetrics department, Tanta University, Egypt and gynecology & obstetrics department, ZNA-Stuivenberg, Antwerp, Belgium. In total, 60 patients were treated. group I: cases treated using uterine morcellator. (30 cases) group II: cases treated using conventional electrical resectoscope. (30 cases) Inclusion criteria: • Patients aged from 25 to 48 complaining of abnormal uterine bleeding or infertility presented with intrauterine submucous fibroid grade zero or one (up to 3 cm) or intracavitary polyp up to 5 cm. Exclusion criteria: • Any contraindication to hysteroscopy procedure or the distention media. • Intrauterine space occupying lesion suspicious for malignancy. Summary and conclusion 92 Procedure: The procedure explained to the patient. Verbal and written consent obtained before beginning the procedure after explanation of the purpose of the research, risks and benefits. The research may reach the end point if the participants refuse to complete. • Premedication: whole cases were given IV Ampicillin-sulbactam 1500mg preoperatively and vaginal misoprostol (Cytotec 200μg) tablet the night before surgery as a preoperative cervical preparation • All procedure were done under general anesthesia • The patient was positioned in the lithotomy position. Draping and sterilization with bovidone iodine was done. • Pelvic examination was done to determine the orientation of the uterus and its size • Evacuation of the bladder, holding the cervix with volsellum then using Hegar dilator set dilating the cervix to Hegar no, 8. • A systematic inspection was done once entering the uterine cavity, focusing on the uterine Summary and conclusion 93 cornua, tubal ostia, fundus, and lateral, anterior and posterior uterine walls.